Free Trial
→ Trump Orders 'National Digital Asset Stockpile' (From Crypto 101 Media) (Ad) Buy SYRE Stock  Free SYRE Stock Alerts

Spyre Therapeutics (SYRE) SEC Filings & 10K Form

Spyre Therapeutics logo
$12.67 +0.25 (+2.01%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$12.60 -0.07 (-0.59%)
As of 04/17/2025 04:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Spyre Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
03/13/2025
11:15 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form EFFECT
03/09/2025
11:15 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form EFFECT
03/07/2025
3:43 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form POS AM
02/27/2025
3:23 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/27/2025
3:23 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/27/2025
3:13 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:02 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
5:06 PM		Spyre Therapeutics, Inc. (Subject)
Spyre Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
8:00 AM		RTW INVESTMENTS, LP (Filed by)
Spyre Therapeutics, Inc. (Subject)
Spyre Therapeutics (Subject)
Form SCHEDULE 13G/A
01/14/2025
4:16 PM		HENDERSON MICHAEL THOMAS (Reporting)
Spyre Therapeutics, Inc. (Issuer)
Spyre Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:08 AM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2024
4:15 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
4:10 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form 424B5
11/14/2024
4:50 PM		Spyre Therapeutics, Inc. (Subject)
Spyre Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
3:33 PM		PERCEPTIVE ADVISORS LLC (Filed by)
Spyre Therapeutics, Inc. (Subject)
Spyre Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:44 AM		Deep Track Capital, LP (Filed by)
Spyre Therapeutics, Inc. (Subject)
Spyre Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:35 AM		Avoro Capital Advisors LLC (Filed by)
Spyre Therapeutics, Inc. (Subject)
Spyre Therapeutics (Subject)
Form SC 13G/A
11/12/2024
9:34 AM		FMR LLC (Filed by)
Spyre Therapeutics, Inc. (Subject)
Spyre Therapeutics (Subject)
Form SC 13G/A
11/08/2024
3:53 PM		Albers Jeffrey W. (Reporting)
Spyre Therapeutics, Inc. (Issuer)
Spyre Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:41 PM		Albers Jeffrey W. (Reporting)
Spyre Therapeutics, Inc. (Issuer)
Spyre Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
3:28 PM		Albers Jeffrey W. (Reporting)
Spyre Therapeutics, Inc. (Subject)
Spyre Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
1:10 PM		Deutsch Peter E. (Filed by)
Spyre Therapeutics, Inc. (Subject)
Spyre Therapeutics (Subject)
Form SC 13G
10/22/2024
2:24 PM		BlackRock, Inc. (Filed by)
Spyre Therapeutics, Inc. (Subject)
Spyre Therapeutics (Subject)
Form SC 13G
10/15/2024
5:10 AM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
11:15 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form EFFECT
10/01/2024
5:26 PM		Sloan Sheldon (Reporting)
Spyre Therapeutics, Inc. (Issuer)
Spyre Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2024
5:34 PM		Sloan Sheldon (Reporting)
Spyre Therapeutics, Inc. (Issuer)
Spyre Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:04 PM		Burrows Scott L (Reporting)
Spyre Therapeutics, Inc. (Issuer)
Spyre Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
8:12 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form 424B3
08/07/2024
3:17 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
8:48 AM		FMR LLC (Filed by)
Spyre Therapeutics, Inc. (Subject)
Spyre Therapeutics (Subject)
Form SC 13G/A
05/30/2024
3:33 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
6:40 AM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:08 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
11:15 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form EFFECT
04/25/2024
3:40 PM		Fairmount Funds Management LLC (Filed by)
Spyre Therapeutics, Inc. (Subject)
Spyre Therapeutics (Subject)
Form SC 13D/A
04/25/2024
3:55 PM		Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Spyre Therapeutics, Inc. (Issuer)
Spyre Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
5:22 PM		Avoro Capital Advisors LLC (Filed by)
Spyre Therapeutics, Inc. (Subject)
Spyre Therapeutics (Subject)
Form SC 13G/A
04/18/2024
7:24 PM		Spyre Therapeutics, Inc. (Filer)
Spyre Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SYRE) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners
Elon Reveals Why There Soon Won’t Be Any Money For Social Security
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...
Colonial Metals | Sponsored
They Won’t Tell You This About Gold
Inflation, digital currency, and government policy are quietly eating away at your savings — and most people w...
American Alternative | Sponsored
🥾⛏️👷‍♂️ What I Learned From Numerous Mine Visits...
Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...
Golden Portfolio | Sponsored
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
How War with China Could Start in 128 Days
The clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...
Behind the Markets | Sponsored
My prediction is coming true
We've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...
InvestorPlace | Sponsored
The Crypto Market is About to Change Lives
I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...
Crypto 101 Media | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored